Oncodrive-CIS: a method to reveal likely driver genes based on the impact of their copy number changes on expression.
A well-established approach for detecting genes involved in tumorigenesis due to copy number alterations (CNAs) is to assess the recurrence of the alteration across multiple samples. Expression data can be used to filter this list of candidates by assessing whether the gene expression significantly...
Main Authors: | David Tamborero, Nuria Lopez-Bigas, Abel Gonzalez-Perez |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23408991/pdf/?tool=EBI |
Similar Items
-
RUBIC identifies driver genes by detecting recurrent DNA copy number breaks
by: Ewald van Dyk, et al.
Published: (2016-07-01) -
Identification and Characterization of Copy Number-Associated Driver Genes in Esophageal Squamous Cell Carcinoma
by: Kexin Jiang, et al.
Published: (2020-01-01) -
CopySwitch—in vivo Optimization of Gene Copy Numbers for Heterologous Gene Expression in Bacillus subtilis
by: Florian Nadler, et al.
Published: (2019-01-01) -
Tumor transcriptome sequencing reveals allelic expression imbalances associated with copy number alterations.
by: Brian B Tuch, et al.
Published: (2010-02-01) -
Antibiotic-Regulated Plasmid Copy Number Variation: A Driver of Antibiotic Resistance?
by: Eldek, Ahmed
Published: (2019)